window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : July 21, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Artificial intelligence

  • Biotech & Pharma Business,Digital & Data,Drug Discovery & Development

    Ingenix raises €13M to expand AI platform for drug development

    Poland-based AI drug development company Ingenix has raised €13 million [...]

    June 8, 2026
  • Clinical & Regulatory,Digital & Data,Drug Discovery & Development,Pharmaceuticals and therapeutics

    Quotient Sciences begins Phase 1 study of AI-designed drug formulation

    Quotient Sciences has begun a Phase 1 clinical study evaluating [...]

    June 6, 2026
  • Central Nervous System,Digital & Data,Drug Delivery & Formulation,Drug Discovery & Development,Therapeutic Areas

    Bonito Biosciences partners with DaltonTx on AI-driven RNA delivery research

    Bonito Biosciences has entered a collaboration with DaltonTx to develop [...]

    June 6, 2026
  • Clinical & Regulatory,Digital & Data,Drug Discovery & Development

    Veristat launches AI biostatistics platform to accelerate clinical trial data readouts

    Veristat has launched an AI-enabled biostatistics platform designed to reduce [...]

    May 15, 2026
  • Clinical & Regulatory,Digital & Data,Drug Discovery & Development

    Evinova and Bristol Myers Squibb collaborate on AI-driven clinical trial optimisation

    Evinova and Bristol Myers Squibb have entered a strategic collaboration [...]

    May 5, 2026
  • Biotech & Pharma Business,Digital & Data,Drug Discovery & Development,Pharmaceuticals and therapeutics

    CytoReason unveils LINA, AI agent accelerated by NVIDIA for pharma R&D

    CytoReason has unveiled LINA, an AI agent designed to support [...]

    May 5, 2026
  • Clinical & Regulatory,Digital & Data,Opinion & Events

    Like the ten leaping Lords, PHARMASEAL takes a leap towards smarter growth in 2026

    With the lords a-leaping, the industry is set to spring [...]

    May 5, 2026
  • Clinical & Regulatory,Digital & Data

    Six geese a-laying: CluePoints’ AI predictions for 2026

    As our Christmas countdown continues, we move from reflections on [...]

    May 5, 2026
  • Drug Discovery & Development,Therapeutic Areas

    Successful treatment for ALS could deliver billions in global value

    New research commissioned by Challenge Works and conducted by the [...]

    May 5, 2026
  • Clinical & Regulatory,Digital & Data,Drug Discovery & Development

    Agentic AI in pharma and how it could transform clinical trials

    Prasanna Rao, Chief Products and Innovation Officer at Saama, explains [...]

    May 5, 2026
Previous123Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Nucs AI taps Segmed’s 150 million imaging studies to strengthen oncology AI
    Categories: Digital & Data, Drug Discovery & Development, Research & Development, Therapeutic Areas
  • Alto Neuroscience raises $100M to expand Phase 3 treatment-resistant depression programme
    Categories: Biotech & Pharma Business, Central Nervous System
  • EC approves first targeted first-line treatment for BRAF-mutant metastatic colorectal cancer
    Categories: Clinical & Regulatory, Pharmaceuticals and therapeutics, Research & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top